These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 23204175)
21. Neuraminidase inhibitors were widely used in the UK during the 2009 influenza A(H1N1) pandemic. Nguyen-Van-Tam JS; Nicholson KG J Clin Virol; 2011 Feb; 50(2):183. PubMed ID: 21112812 [No Abstract] [Full Text] [Related]
22. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Monto AS; McKimm-Breschkin JL; Macken C; Hampson AW; Hay A; Klimov A; Tashiro M; Webster RG; Aymard M; Hayden FG; Zambon M Antimicrob Agents Chemother; 2006 Jul; 50(7):2395-402. PubMed ID: 16801417 [TBL] [Abstract][Full Text] [Related]
23. Antivirals for pandemic influenza: a triumph of policy over evidence? Thompson M; Heneghan C Trends Pharmacol Sci; 2010 Sep; 31(9):391-3. PubMed ID: 20573406 [No Abstract] [Full Text] [Related]
25. Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: analysis of 1000 hospitalized children. Sugaya N; Shinjoh M; Mitamura K; Takahashi T J Infect; 2011 Oct; 63(4):288-94. PubMed ID: 21722665 [TBL] [Abstract][Full Text] [Related]
26. Benefit of Early Initiation of Neuraminidase Inhibitor Treatment to Hospitalized Patients With Avian Influenza A(H7N9) Virus. Zheng S; Tang L; Gao H; Wang Y; Yu F; Cui D; Xie G; Yang X; Zhang W; Ye X; Zhang Z; Wang X; Yu L; Zhang Y; Yang S; Liang W; Chen Y; Li L Clin Infect Dis; 2018 Mar; 66(7):1054-1060. PubMed ID: 29077848 [TBL] [Abstract][Full Text] [Related]
27. Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic. Beck CR; Sokal R; Arunachalam N; Puleston R; Cichowska A; Kessel A; Zambon M; Nguyen-Van-Tam JS; Influenza Other Respir Viruses; 2013 Jan; 7 Suppl 1(Suppl 1):14-24. PubMed ID: 23279893 [TBL] [Abstract][Full Text] [Related]
28. Widespread use of neuraminidase inhibitors in Japan. Sugaya N J Infect Chemother; 2011 Oct; 17(5):595-601. PubMed ID: 21850418 [TBL] [Abstract][Full Text] [Related]
29. Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico. Chowell G; Viboud C; Simonsen L; Miller MA; Echevarría-Zuno S; González-León M; Aburto VH BMC Infect Dis; 2012 Apr; 12():97. PubMed ID: 22520743 [TBL] [Abstract][Full Text] [Related]
30. Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and/or meta-analyses. Doll MK; Winters N; Boikos C; Kraicer-Melamed H; Gore G; Quach C J Antimicrob Chemother; 2017 Nov; 72(11):2990-3007. PubMed ID: 28961794 [TBL] [Abstract][Full Text] [Related]
31. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016. Gubareva LV; Besselaar TG; Daniels RS; Fry A; Gregory V; Huang W; Hurt AC; Jorquera PA; Lackenby A; Leang SK; Lo J; Pereyaslov D; Rebelo-de-Andrade H; Siqueira MM; Takashita E; Odagiri T; Wang D; Zhang W; Meijer A Antiviral Res; 2017 Oct; 146():12-20. PubMed ID: 28802866 [TBL] [Abstract][Full Text] [Related]
32. Effectiveness of neuraminidase inhibitors for severe influenza. Fry AM Lancet Respir Med; 2014 May; 2(5):346-8. PubMed ID: 24815800 [No Abstract] [Full Text] [Related]
34. Early administration of neuraminidase inhibitors in adult patients hospitalized for influenza does not benefit survival: a retrospective cohort study. Choi SH; Kim T; Park KH; Kwak YG; Chung JW; Lee MS Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1673-1677. PubMed ID: 28417272 [TBL] [Abstract][Full Text] [Related]
35. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: influence of neuraminidase inhibitors. Delgado-Rodríguez M; Castilla J; Godoy P; Martín V; Soldevila N; Alonso J; Astray J; Baricot M; Cantón R; Castro A; Gónzález-Candelas F; Mayoral JM; Quintana JM; Pumarola T; Tamames S; Sáez M; Domínguez A; J Antimicrob Chemother; 2012 Jul; 67(7):1739-45. PubMed ID: 22467633 [TBL] [Abstract][Full Text] [Related]
36. Prompt use of neuraminidase inhibitors improves survival of children severely ill with flu. McCarthy M BMJ; 2013 Nov; 347():f7127. PubMed ID: 24285175 [No Abstract] [Full Text] [Related]
37. Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1). Uyeki T N Engl J Med; 2009 Dec; 361(23):e110. PubMed ID: 19923564 [No Abstract] [Full Text] [Related]
38. Global transmission of oseltamivir-resistant influenza. Moscona A N Engl J Med; 2009 Mar; 360(10):953-6. PubMed ID: 19258250 [No Abstract] [Full Text] [Related]
39. Oseltamivir for the treatment of H1N1 influenza during pregnancy. Beigi RH; Pillai VC; Venkataramanan R; Caritis SN Clin Pharmacol Ther; 2015 Oct; 98(4):403-5. PubMed ID: 26108913 [TBL] [Abstract][Full Text] [Related]
40. Virus susceptibility and clinical effectiveness of anti-influenza drugs during the 2010-2011 influenza season in Russia. Leneva IA; Burtseva EI; Yatsyshina SB; Fedyakina IT; Kirillova ES; Selkova EP; Osipova E; Maleev VV Int J Infect Dis; 2016 Feb; 43():77-84. PubMed ID: 26775570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]